Cargando…
Survival benefits from neoadjuvant treatment in gastric cancer: a systematic review and meta-analysis
BACKGROUND: Surgery is the main treatment option for patients with local gastric cancer. However, surgery alone is usually not sufficient for stomach cancer patients, and combined therapies are recommended for these patients. In recent studies, some preoperative treatments have shown benefits. Howev...
Autores principales: | Hu, Jianwen, Yang, Yanpeng, Ma, Yongchen, Ning, Yingze, Chen, Guowei, Liu, Yucun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252040/ https://www.ncbi.nlm.nih.gov/pubmed/35788246 http://dx.doi.org/10.1186/s13643-022-02001-7 |
Ejemplares similares
-
Proliferation Cycle Transcriptomic Signatures are Strongly associated With Gastric Cancer Patient Survival
por: Hu, Jianwen, et al.
Publicado: (2021) -
M2 Macrophage-Based Prognostic Nomogram for Gastric Cancer After Surgical Resection
por: Hu, Jianwen, et al.
Publicado: (2021) -
CAF promotes chemoresistance through NRP2 in gastric cancer
por: Yang, Yanpeng, et al.
Publicado: (2021) -
Macrophage-derived SPARC Attenuates M2-mediated Pro-tumour Phenotypes
por: Hu, Jianwen, et al.
Publicado: (2020) -
Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer
por: Ma, Yongchen, et al.
Publicado: (2018)